Sun Pharmaceutical Industries Share Price Today - Live Blog for March 27, 2025

Sun Pharmaceutical Industries Ltd witnessed a -0.02% drop in its share price and is currently trading at ₹1,733.00. With the stock's PE at 36.8900 and the industry PE at 34.3929, investors are weighing their options.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.06%, reaching the current market price of ₹1,733.00. This surge is indicative of the stock's recent positive performance.

Sun Pharmaceutical Industries Ltd's share price has experienced a notable 0.14% upswing, and it's currently trading at ₹1,733.00 per share. Investors are closely watching this development.

Demonstrating a commendable 0.03% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,734.55. In terms of valuation, the stock maintains a PE ratio of 36.8900, while the industry PE ratio stands at 34.3929.

Demonstrating a commendable 0.06% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,731.35. In terms of valuation, the stock maintains a PE ratio of 36.8900, while the industry PE ratio stands at 34.3929.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.35% uptick in its share price. As a result, it's now actively trading at ₹1,730.10 per share, making it an attractive option for investors.

Following a noteworthy 0.35% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,730.10. When it comes to valuation, this stock has a PE ratio of 36.8900, with the industry PE ratio at 34.3929.

Sun Pharmaceutical Industries Ltd shares saw a -0.22% decrease, reaching a current market price of ₹1,721.80. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 36.8900, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.22% drop, and it's now trading at ₹1,721.80 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Sun Pharmaceutical Industries Ltd observed a -0.06% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,724.10. The stock has a PE ratio of 36.8900, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.01% decline and is currently trading at ₹1,724.75 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

With a -0.01% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,724.75. This development raises questions about the factors behind the decline. The stock's PE ratio is 36.8900, while the industry PE is 34.3929.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.02%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,725.25, and market participants are assessing the implications. The stock has a PE ratio of 36.8900, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.01% surge in its share price and is presently trading at ₹1,724.95, captivating the attention of market participants.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.14%, with the current market value at ₹1,724.75 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Sun Pharmaceutical Industries Ltd share price has declined by -0.14%, and it's currently trading at ₹1,724.75. The stock maintains a PE of 36.8900, while the industry PE is 34.3929, prompting discussions about its valuation.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.14%, a development that warrants careful analysis. Presently trading at ₹1,724.75, investors are assessing whether this presents an opportunity or a risk.

Sun Pharmaceutical Industries Ltd observed a -0.14% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,724.75. The stock has a PE ratio of 36.8900, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd experienced a -0.15% dip in its share price and is currently trading at ₹1,725.50. The stock has a PE ratio of 36.8900, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

With a -0.15% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,725.50. The stock is currently trading at a PE of 36.8900, while the industry PE is 34.3929, prompting investors to assess its value proposition.

Sun Pharmaceutical Industries Ltd experienced a -0.15% downturn in its share price, and it's currently trading at ₹1,725.50. This situation is generating interest among value investors who are evaluating the stock's potential.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.18% surge in its share price and is presently trading at ₹1,728.20. The increased investor interest is driving this surge.

Sun Pharmaceutical Industries Ltd shares experienced a -0.07% reduction, with the current market price at ₹1,724.65. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Sun Pharmaceutical Industries Ltd shares saw a -0.04% decrease, reaching a current market price of ₹1,725.15. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 36.8900, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.08% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,725.90 per share. The stock has an ROE of 15.9938% and debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.03%, a situation worth noting. At present, the stock is trading at ₹1,724.55. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 36.8900, while the industry PE ratio is 34.3929.

The share price of Sun Pharmaceutical Industries Ltd experienced an impressive 0.06% upswing and is currently trading at ₹1,726.10, indicating strong market sentiment.

With a -0.19% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,724.80. The stock is currently trading at a PE of 36.8900, while the industry PE is 34.3929, prompting investors to assess its value proposition.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.28%, a situation worth noting. At present, the stock is trading at ₹1,728.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 36.8900, while the industry PE ratio is 34.3929.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.10%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,734.10, and market participants are assessing the implications. The stock has a PE ratio of 36.8900, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

With a -0.26% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,730.50. Investors should examine the factors driving this decline. The stock's PE ratio is 36.8900, whereas the industry PE ratio stands at 34.3929.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.26%, a development that warrants careful analysis. Presently trading at ₹1,730.50, investors are assessing whether this presents an opportunity or a risk.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 3.15%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,754.60 per share.

The stock price of Sun Pharmaceutical Industries Ltd enjoyed a significant 3.15% boost, with the current market value at ₹1,754.60 per share. This surge has not gone unnoticed by investors.